Central Bank & Trust CO Baxter International Inc Transaction History

Central Bank & Trust CO

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 13, 2023	SELL	$39.98 - $47.68 $1,039 - $1,239	-26 Reduced 21.67%	94 $4,000
Q1 2023 Apr 13, 2023	BUY	$37.58 - $52.57 $977 - $1,366	26 Added 27.66%	120 $4,000
Q2 2021 Jul 16, 2021	SELL	$80.5 - $88.01 $10,143 - $11,089	-126 Reduced 57.27%	94 $8,000
Q2 2020 Jul 15, 2020	BUY	$78.66 - $94.14 $7,394 - $8,849	94 Added 74.6%	220 $19,000
Q1 2020 Apr 14, 2020	SELL	$71.57 - $93.3 $6,727 - $8,770	-94 Reduced 42.73%	126 $10,000
Q3 2019 Oct 23, 2019	BUY	$81.4 - $89.78 $7,651 - $8,439	94 Added 74.6%	220 $19,000
Q2 2019 Jul 16, 2019	BUY	$73.44 - $82.41 $1,909 - $2,142	26 Added 26.0%	126 $10,000
Q1 2019 Apr 22, 2019	SELL	$64.48 - $81.31 $3,224 - $4,065	-50 Reduced 33.33%	100 $8,000
Q3 2018 Nov 23, 2018	BUY	$70.71 - $77.75 $10,606 - $11,662	150 New	150 $12,000

1,006

451M

2.79M

2.44M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $16.7B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Central Bank & Trust CO, based on Form 13F filings with the SEC.

Stay updated on Central Bank & Trust CO with notifications on news.